Madhu Midathada is an Oncology physician affiliated with Nebraska Hematology-Oncology. OpenAlex indexes 14 publications with 640 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4004 Pioneer Woods Dr
Lincoln, NE 685067548
Telephone
402-484-4900Provider last certified this registry record 1 May 2023.
Industry payments
34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20256 payments
- ABBVIE INC.Program year20257 payments
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
42.4%Iron, parenteral preparations40.8%Ferric carboxymaltose100%Part B, office-administered≥67 patientsThrombopoietin Receptor Agonist0.8%Romiplostim100%Part B, office-administered≥11 patients+ 4 more classes in this area
Cancer & immunology
29.2%PD-1 inhibitor12.7%Pembrolizumab66%Nivolumab34%Part B, office-administered≥27 patientsCD38-directed Cytolytic Antibody9.6%Daratumumab100%Part B, office-administered≥25 patients+ 11 more classes in this area
Metabolism & gastrointestinal
16.5%Substance P/Neurokinin-1 Receptor Antagonist7.9%Aprepitant100%Part B, office-administered≥43 patientsOther antiemetics5.7%Fosaprepitant100%Part B, office-administered≥28 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Hodgkin lymphoma presenting as paraneoplastic cerebellar degeneration: A case report
SAGE Open Medical Case Reports
2025 - Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis
Journal of Vascular Surgery Venous and Lymphatic Disorders
2019
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”